Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-6901
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Dabigatran Versus Warfarin After Bioprosthesis Valve Replacement for the Management of Atrial Fibrillation Postoperatively: DAWA Pilot Study ; day:18 ; month:2 ; year:2016 ; pages:1-6
Drugs in R & D ; (18.2.2016), 1-6
- Creator
-
Durães, André Rodrigues
- Contributor
-
Souza Roriz, Pollianna de
Almeida Nunes, Bianca de
Albuquerque, Felipe Pinho e.
Bulhões, Fábio Vieira de
Souza Fernandes, Andre Mauricio de
Aras, Roque
SpringerLink (Online service)
- DOI
-
10.1007/s40268-016-0124-1
- URN
-
urn:nbn:de:1111-2016022013562
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Durães, André Rodrigues
- Souza Roriz, Pollianna de
- Almeida Nunes, Bianca de
- Albuquerque, Felipe Pinho e.
- Bulhões, Fábio Vieira de
- Souza Fernandes, Andre Mauricio de
- Aras, Roque
- SpringerLink (Online service)
Other Objects (12)
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Optimal INR level for warfarin therapy after mechanical mitral valve replacement
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China
Warfarin-associated intracranial haemorrhage in pregnant woman with double mechanical valve replacement: a case presentation
Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients
Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Optimal INR level for warfarin therapy after mechanical mitral valve replacement
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China
Warfarin-associated intracranial haemorrhage in pregnant woman with double mechanical valve replacement: a case presentation
Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients
Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry
A clinical study of genetic testing to guide the dosing of warfarin after heart valve replacement
Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
Dabigatran and warfarin in nonvalvular atrial fibrillation or atrial flutter in outpatient clinic practice in Brazil
Optimal INR level for warfarin therapy after mechanical mitral valve replacement
Healthcare utilization and costs for patients initiating Dabigatran or Warfarin
Comparative effectiveness of rivaroxaban versus warfarin or dabigatran for the treatment of patients with non-valvular atrial fibrillation
Dabigatran exhibits low intensity of left atrial spontaneous echo contrast in patients with nonvalvular atrial fibrillation as compared with warfarin
Cost‐effectiveness analysis of dabigatran, rivaroxaban and warfarin in the prevention of stroke in patients with atrial fibrillation in China
Warfarin-associated intracranial haemorrhage in pregnant woman with double mechanical valve replacement: a case presentation
Correlation between single nucleotide polymorphisms in CYP4F2 and warfarin dosing in chinese valve replacement patients
Outcome of mitral valve plasty or replacement: atrial fibrillation an effect modifier
Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry